Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

Market Cap	3.21B +7.7%
Revenue (ttm)	1.11B +9.8%
Net Income	86.79M -27.9%
EPS	0.83 -27.8%
Shares Out	105.91M
PE Ratio	36.50
Forward PE	n/a
Dividend	0.20 (0.66%)
Ex-Dividend Date	n/a

Volume	1,617,100
Average Volume	2,975,004
Open	30.18
Previous Close	30.31
Day's Range	30.13 - 30.50
52-Week Range	26.56 - 42.88
Beta	-0.12
RSI	36.78
Earnings Date	Apr 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 933
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002864

Financial Performance

In 2025, SHE:002864's revenue was 1.14 billion, an increase of 17.15% compared to the previous year's 973.86 million. Earnings were 96.28 million, a decrease of -19.95%.